Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF)

Archivum Immunologiae et Therapiae Experimentalis

Volumn 44, Issue 4, 1996, Pages 255-258

  Góra Tybor, Joanna ^a   Krykowski, Euzebiusz ^a   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

drug induced agranulocytosis; granulocyte colony stimulating factor; granulocyte macrophage colony stimulating factor

Indexed keywords

AMINOPHENAZONE; CHLORPROMAZINE; COTRIMOXAZOLE; DAPSONE; DIPYRONE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; THIAMAZOLE;

ADULT; AGRANULOCYTOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMATOPOIESIS; HUMAN; INFECTION; MALE; NEUTROPHIL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; AGRANULOCYTOSIS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIFUNGAL AGENTS; DRUG EVALUATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFECTION CONTROL; MALE; METHIMAZOLE; MIDDLE AGED;

EID: 0029804335     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. BJORKHOLM M., PISA P., ARVER S. and BERAN M. (1992): Haematologic effects of granulocyte-macrophage colony stimulating factor in a patient with thiainazole-induced agranulocytosis. J. Int. Med., 232, 443-445.
2. BRADFORD C. R., ONG E.L.C., HENDRICK D. J. and SAUNDERS P.W.G. (1993): Use of colony stimulating factors for the treatment of drug-induced agranulocytosis. Br. J. Haematol., 84, 182-183.
3. CAPPELLARI G., GAIO A., CAVALLARO A., CARDAIOLI C, SIMONI L., LA VALLE R. and AGOSTINI C. (1993): Correspondence. Br. J. Haematol., 84, 183-184.
4. DELLANOY A. (1992): GM-CSF therapy for drug-induced agranulocytosis. J. Int. Med., 231, 296-271.
5. GENET P., PAULIK M., LIONNET F. and BREMONT C. (1994): Agranulocytosis induced by synthetic antithyroid drugs: efficacy of hematopoietic growth factors. Ann. Endocrinol., 55, 39-42.
6. GERL A., GERHARTZ H. and WILMANNS W. (1990): GM-CSF for agranulocytosis. J. Intern. Med., 30, 90-91.
7. KOTLAREK-HAUS S., PODOLAK-DAWIDZIAK M. and WRÓBEL T. (1994): Treatment of drug-induced agranulocytosis with granulocyte colony stimulating factor (G-CSF). Pol. Arch. Med. Wew., 91, 127-131.
8. MAGNER J. A. and SNYDER D. K. (1994): Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF). Thyroid, 4, 295-296.
9. SKOTNICKI A. (1994): Polekowe uszkodzenie szpiku. Post. Nauk Med., 7, 246-253.
10. SPRIKKELMAN A., DE WOLF J. Th. and VELLENGA E. (1994): The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases. Leukemia, 8, 2031-2036.
11. TAJIRI J., NOGUCHI S., OKAMURA S., MORITA M., TAMARU M., MURAKAMI M. and NIHO Y. (1993): Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia. Arch. Intern. Med., 153, 509-513.